The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Blockade of the Bcr-Abl Kinase Activity Induces Apoptosis of Chronic Myelogenous Leukemia Cells by Suppressing Signal Transducer and Activator of Transcription 5–Dependent Expression of Bcl-XL
Open accessAbstract
Bcr-Abl–expressing leukemic cells are highly resistant to apoptosis induced by chemotherapeutic drugs. Although a number of signaling molecules have been shown to be activated by the Bcr-Abl kinase, the antiapoptotic pathway triggered by this oncogene has not been elucidated. Here, we show that the interleukin 3-independent expression of the antiapoptotic protein, Bcl-xL, is induced by Bcr-Abl through activation of signal transducer and activator of transcription (Stat)5. Inhibition of the Bcr-Abl kinase activity in Bcr-Abl–expressing cell lines and CD34+ cells from chronic myelogenous leukemia (CML) patients induces apoptosis by suppressing the capacity of Stat5 to interact with the bcl-x promoter. Interestingly, after inhibition of the Bcr-Abl kinase, the expression of Bcl-xL is downregulated more rapidly in chronic phase than in blast crisis CML cells, suggesting an involvement of this protein in disease progression. Overall, we describe a novel antiapoptotic pathway triggered by Bcr-Abl that may contribute to the resistance of CML cells to undergo apoptosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. B. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 2,967
Catlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernández-Luna, J. L., Nuñez, G., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80011-4 · Cited by 1,638
Fused transcript of abl and bcr genes in chronic myelogenous leukaemia
Shtivelman, E., Lifshitz, B., Gale, R. P., & Canaani, E. (1985) · Nature · doi:10.1038/315550a0 · Cited by 1,611
Ihle, J. N. (1995) · Nature · doi:10.1038/377591a0 · Cited by 1,203
Fetal Anemia and Apoptosis of Red Cell Progenitors in Stat5a−/−5b−/− Mice
Socolovsky, M., Fallon, A. E. J., Wang, S., Brugnara, C., & Lodish, H. F. (1999) · Cell · doi:10.1016/s0092-8674(00)81013-2 · Cited by 696
Carroll, M., Ohno-Jones, S., Tamura, S., Buchdunger, E., Zimmermann, J., Lydon, N. B., Gilliland, D. G., & Druker, B. J. (1997) · Blood · doi:10.1182/blood.v90.12.4947 · Cited by 554
Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia
Bedi, A., Zehnbauer, B., Barber, J., Sharkis, S., & Jones, R. (1994) · Blood · doi:10.1182/blood.v83.8.2038.2038 · Cited by 508
Mui, A. L., Wakao, H., O'Farrell, A. M., Harada, N., & Miyajima, A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07100.x · Cited by 493
Carlesso, N., Frank, D. A., & Griffin, J. D. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.811 · Cited by 483
McGahon, A., Bissonnette, R., Schmitt, M., Cotter, K., Green, D., & Cotter, T. (1994) · Blood · doi:10.1182/blood.v83.5.1179.1179 · Cited by 472
In Vivo Eradication of Human BCR/ABL-Positive Leukemia Cells With an ABL Kinase Inhibitor
le Coutre, P., Mologni, L., Cleris, L., Marchesi, E., Buchdunger, E., Giardini, R., Formelli, F., & Gambacorti-Passerini, C. (1999) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/91.2.163 · Cited by 374
Bedi, A., Barber, J., Bedi, G., el-Deiry, W., Sidransky, D., Vala, M., Akhtar, A., Hilton, J., & Jones, R. (1995) · Blood · doi:10.1182/blood.v86.3.1148.1148 · Cited by 349
Amarante-Mendes, G. P., Naekyung Kim, C., Liu, L., Huang, Y., Perkins, C. L., Green, D. R., & Bhalla, K. (1998) · Blood · doi:10.1182/blood.v91.5.1700 · Cited by 316
Chai, S. K., Nichols, G. L., & Rothman, P. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.10.4720 · Cited by 280
Silva, M., Benito, A., Sanz, C., Prosper, F., Ekhterae, D., Nuñez, G., & Fernandez-Luna, J. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22165 · Cited by 277
Self-citationNieborowska-Skorska, M., Wasik, M. A., Slupianek, A., Salomoni, P., Kitamura, T., Calabretta, B., & Skorski, T. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.8.1229 · Cited by 271
Gazit, A., Osherov, N., Posner, I., Yaish, P., Poradosu, E., Gilon, C., & Levitzki, A. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00110a022 · Cited by 259
Verfaillie, C. M., McCarthy, J. B., & McGlave, P. B. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115985 · Cited by 249
Amarante-Mendes, G. P., McGahon, A. J., Nishioka, W. K., Afar, D. E., Witte, O. N., & Green, D. R. (1998) · Oncogene · doi:10.1038/sj.onc.1201664 · Cited by 226
Fujio, Y., Kunisada, K., Hirota, H., Yamauchi-Takihara, K., & Kishimoto, T. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119484 · Cited by 200
Bcl-xL is phosphorylated in malignant cells following microtubule disruption.
Poruchynsky, M. S., Wang, E. E., Rudin, C. M., Blagosklonny, M. V., & Fojo, T. (1998) · PubMed · Cited by 183
Fujita, N., Nagahashi, A., Nagashima, K., Rokudai, S., & Tsuruo, T. (1998) · Oncogene · doi:10.1038/sj.onc.1202065 · Cited by 160
IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line
Dumon, S., Santos, S. C. R., Debierre-Grockiego, F., Gouilleux-Gruart, V, Cocault, L., Boucheron, C., Mollat, P., Gisselbrecht, S., & Gouilleux, F. (1999) · Oncogene · doi:10.1038/sj.onc.1202796 · Cited by 159
Sirard, C., Laneuville, P., & Dick, J. E. (1994) · Blood · doi:10.1182/blood.v83.6.1575.1575 · Cited by 133
Prósper, F., Stroncek, D. F., McCarthy, J. B., & Verfaillie, C. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci188 · Cited by 133
Apoptosis induced by erythroid differentiation of human leukemia cell lines is inhibited by Bcl-XL
Benito, A., Silva, M., Grillot, D., Núñez, G., & Fernandez-Luna, J. (1996) · Blood · doi:10.1182/blood.v87.9.3837.bloodjournal8793837 · Cited by 128
Self-citationActivation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL
Sattler, M., & Salgia, R. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(96)00047-0 · Cited by 112
Cambier, N., Chopra, R., Strasser, A., Metcalf, D., & Elefanty, A. G. (1998) · Oncogene · doi:10.1038/sj.onc.1201490 · Cited by 110
Skórski, T., Nieborowska-Skorska, M., Wlodarski, P. K., Wasik, M. A., Trotta, R., Kanakaraj, P., Salomoni, P., Antonyak, M., Martinez, R., Majewski, M., et al. (1998) · Blood · doi:10.1182/blood.v91.2.406 · Cited by 86
Ray, S. K., Bullock, G., Núñez, G., Tang, C., Ibrado, A. M., Huang, Y., & Bhalla, K. N. (1996) · PubMed · Cited by 54
Beck, Z., Bácsi, A., Kovács, E. M., KISS, J., Kiss, A., Balogh, E., Telek, B., th, F. D. T., Andirkócute, I., Oláh, É., et al. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809057542 · Cited by 24
Interferon Induces Up-regulation of Spi-1/PU.1 in Human Leukemia K562 Cells
Gutiérrez, P., Delgado, M. D., Richard, C., Moreau-Gachelin, F., & León, J. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7760 · Cited by 13
Cited by
Blume-Jensen, P., & Hunter, T. (2001) · Nature · doi:10.1038/35077225 · Cited by 3,738
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278
Molecular mechanisms of drug resistance
Longley, D., & Johnston, P. (2005) · The Journal of Pathology · doi:10.1002/path.1706 · Cited by 1,672
The molecular biology of chronic myeloid leukemia
Deininger, M. W. N., Goldman, J. M., & Melo, J. V. (2000) · Blood · doi:10.1182/blood.v96.10.3343 · Cited by 1,667
Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug
Capdeville, R., Buchdunger, E., Zimmermann, J., & Matter, A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd839 · Cited by 1,389
Metadata
- Authors
- Horita, M., Andreu, E. J., Benito, A., Arbona, C., Sanz, C., Benet, I., Prosper, F., & Fernandez-Luna, J. L.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2000-03-13
- Volume
- 191
- Issue
- 6
- Pages
- 977-984
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2112127173
- Cited by
- 366
- References
- 32
- FWCI
- 19.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.